A Retrospective Database Study to Evaluate Rates of Influenza and Related Diagnoses between Patients Treated with Tofacitinib and Other Systemic Therapies within Cohorts of RA, PsA, and UC Patients: A Post-Authorization Safety Study of Tofacitinib

16/02/2021
23/04/2024
EU PAS number:
EUPAS39242
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

FINAL A3921383 Non-Interventional Protocol Study 01 December 2020

English (1.86 MB - PDF) View document
Updated protocol

A3921383 Non-Interventional Protocol Study Amendment 1 (CLEAN) 29 October 2021_Redacted

First published: 22/02/2024
English (3.09 MB - PDF) View document
Study results
Study results

A3921383 Non Interventional Study Report Abstract 10 February 2023_Redacted

English (287.26 KB - PDF) View document
Study report
Study report

A3921383 Non Interventional Study Report 10 February 2023_Redacted

English (8.19 MB - PDF) View document
Other information